Compounds > sennoside a&b
Page last updated: 2024-11-04

sennoside a&b and Narcotic Bowel Syndrome

sennoside a&b has been researched along with Narcotic Bowel Syndrome in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Outpatients ≥ 18 years old with cancer, at risk of or already experiencing opioid-induced constipation, were randomly assigned to begin a standard bowel protocol of escalating doses of sennosides or PEG, plus a dummy preparation."2.94PEG vs. sennosides for opioid-induced constipation in cancer care. ( Gobbo, M; Hawley, P; MacKenzie, H, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hawley, P1
MacKenzie, H1
Gobbo, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
OMAMA-study - Prevention of Opioid-induced Constipation in Patients With Advanced Cancer[NCT05216328]Phase 4330 participants (Anticipated)Interventional2022-12-02Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for sennoside a&b and Narcotic Bowel Syndrome

ArticleYear
PEG vs. sennosides for opioid-induced constipation in cancer care.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Cross-Over Studies; Defecation; Dou

2020